BetterLife Pharma Inc.

OTC: BETRF · Healthcare · Biotechnology

Canadian filerHQ Vancouver, BCCIK 0001464165Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 47

v0.1 · 5/100 weight · pillars only

↑ listing tenure, return on assets · ↓ filing timeliness, Altman-Z

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$121.2k

Employees

Market cap

$21.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$121.2k-$121.2k2018

Operating income-$1.0M-$1.0M2018

Total assets$383.8k$383.8k2018

Liabilities$429.2k$429.2k2018

Equity-$45.4k-$45.4k2018

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

BetterLife Pharma Inc. earned -$121.2k in FY2018 net income.

Peers · Healthcare

MediPharm Labs Corp.61C Guided Therapeutics, Inc.42D Nova Leap Health Corp.75B+Allarity Therapeutics, Inc.24D

Key facts

CEOAhmad Doroudian

SectorHealthcare

IndustryBiotechnology

HeadquartersVancouver, BC

ExchangeOTC: BETRF

Employees7

IPO date2010-09-01

Latest filings

6-K2026-06-26 6-K2026-06-25 20-F2026-06-01 6-K2026-04-13 6-K2025-09-29 6-K2025-07-28 6-K2025-06-27 6-K2025-06-23

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.